An HSJ roundtable, in association with Johnson & Johnson, considered how the NHS can offer a consistent bariatric service
This event was fully funded and initiated by Johnson & Johnson who worked with HSJ to decide on the topic it covered. HSJ entirely organised the event and retained editorial control over it and this associated report. Johnson & Johnson was able to review this report in advance of publication for factual accuracy and compliance checks. None of the panellists were compensated by Johnson & Johnson or HSJ for their participation in the roundtable.
Obesity will be one of the biggest challenges for the NHS in the coming decades. Its complications – such as diabetes, cardiovascular disease and cancer – will be enormously costly for the NHS and society more generally.
In association with
A new generation of weight reduction medicines holds hope for some but will be expensive for the NHS and are currently only available to a small proportion of eligible patients.
Bariatric surgery is another option for some patients with a high body mass index. However, access continues to be limited, despite its proven effectiveness, with variations across the country in how easy it is for patients to be treated. This HSJ roundtable, in association with Johnson & Johnson, looked at these issues and asked what is needed to provide more consistent services.
Read the detailed report here.
Panellists
- Omer Al-Taan, bariatric surgeon, Luton and Dunstable Hospital
- James Byrne, president, British Obesity and Metabolic Surgery Society and consultant surgeon
- Carly Anna Hughes, GP with a special interest in obesity
- Julia McGinley, divisional business manager, Maidstone and Tunbridge Wells Trust
- Alex Miras, professor of endocrinology at Ulster University and senior clinical lecturer at Imperial College
- Catherine Thompson, associate director – planned care, West Yorkshire Integrated Care Board
- Anna Winyard, solutions architect, Johnson & Johnson
- Alison Moore, roundtable chair, HSJ
GB_JMT_DIGI_389143
